Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The study aims to investigate the prognostic significance of olfactory function in patients with glioblastoma. We are examining olfactory function at various points during therapy and correlating the results with survival data. In addition, neurocognitive tests will be carried out to correlate the results of olfactory function with the patient's cognitive abilities. Investigations into the quality of life and psychological condition of the patients are also performed. In addition to the cohort of glioblastoma patients, there is a control cohort without tumor disease in which the olfactory testing is also carried out in order to have a comparison.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• At least 18 years of age

• Newly-diagnosed glioblastoma (IDH wild-type)

• Never received prior chemotherapy

• Never received radiotherapy to the head or neck before

• KPS ≥ 70

• No history of severe head or brain trauma requiring ICU admission or classified as Glasgow Coma Scale grade 3

• No respiratory infection at the time of inclusion

• No significant aphasia

Locations
Other Locations
Germany
University Hospital Essen, Department of Neurology, Division of Clinical Neuro-Oncology
RECRUITING
Essen
Department of Neurosurgery
RECRUITING
Münster
Contact Information
Primary
Christoph Oster, Dr. med.
christoph.oster@uk-essen.de
+49201-723-82598
Backup
Sied Kebir, PD Dr. med.
sied.kebir@uk-essen.de
+49201-723-83133
Time Frame
Start Date: 2023-05-03
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 128
Treatments
Newly-diagnosed glioblastoma cohort
Control cohort
Control group of patients with non-tumourous (neurological) diseases not primarily associated with an olfactory dysfunction
Sponsors
Collaborators: Münster University Hospital, Germany
Leads: Sied Kebir

This content was sourced from clinicaltrials.gov

Similar Clinical Trials